Remote Monitoring Using a Digital Platform
Optimizing Chronic Pain Management Through Remote Monitoring: A Proof-of-Concept Study Using a Digital Platform
- Chronic Pain
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Hackensack Meridian Health
- Enrolment target
- 50
- Started
- 18 December 2025
- Main results due
- 10 February 2028
- Study sites
- 2
- Registry updated
- 23 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria:
* Signed informed consent form (ICF)
* Age: Adults aged 18 years or older
* Ability to comply with the study protocol, including having a smartphone and being able and willing to access the application on a regular basis. To use all functionalities of the application, the user's smartphone must comply with the minimum system requirements (Android version 8.0 or above, iOS version 13.0 or above)
* Have a valid email address
* Have a valid phone number
* Diagnosis Codes:
* Patients with a confirmed diagnosis of Chronic Pain Syndrome based on ICD-10 code G89.4 as primary diagnosis.
■ Including Fibromyalgia M79.7
* Patient with a confirmed secondary diagnosis
* Back Pain M54.5
* Neck Pain M54.2
* Joint Pain M25.5
* Medications: N/A
* Test/Lab results: N/A
* Study sites: Hackensack Meridian Health Neuroscience Institute located at 650 From Road, Suite 506, Paramus, NJ, 07652
* Service: Outpatient
Exclusion Criteria:
* Age: Patients below 18 years of age
* Unable or unwilling to provide informed consent
* Presence of an active diagnosis of a comorbid cognitive impairment such as dementia or mild cognitive impairment
* Lack of access to a smartphone device or inability to demonstrate proficiency in downloading and using mobile applications
* Physical limitations that prevent participation in a basic home exercise program
* Considered by the investigator to have a condition that precludes safe or active participation in the trialWhat this study is about
In the sponsor’s own words, from the registry.
A single site, proof-of-concept prospective behavioral interventional study testing remote monitoring among people living with chronic pain. The study is a single arm study. The duration of the study will be 12-18 months, enrolling 100 and following up to six months post enrollment/ baseline. A convenience sample of 50 patients with CP meeting the inclusion criteria will participate in a 3 to 6 month remote monitoring program utilizing FitCam. Since the time period to conduct this study is 12 months.
FitCam portal/ app will be utilized for the intervention and the outcome will be recorded to observe if remote monitoring has an affect in the health outcome compared to baseline health quality of the patient.
Study sites(2)
Hackensack University Medical Center
Hackensack, New Jersey, United States
Recruiting
Hackensack Meridian Health Neuroscience Institute
Paramus, New Jersey, United States
Recruiting
Showing 2 of 2 sites. 2 of the 2 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07837102. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me